Results 231 to 240 of about 3,206,200 (405)

Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide

open access: green, 2018
Daniel Bengtsson   +12 more
openalex   +2 more sources

Epidemiology of acquired hypothalamic obesity following traumatic brain injury and nonspecific hypothalamic microinjury: A nationwide German claims data analysis

open access: yesJournal of Neuroendocrinology, EarlyView.
Abstract Acquired hypothalamic obesity (aHO) is characterized by rapid and persistent weight gain resulting from structural or functional damage to the hypothalamus, typically accompanied by neuroendocrine dysfunction. While aHO is well described in the context of hypothalamic or suprasellar tumors, particularly craniopharyngioma, little is known about
Julian Witte   +5 more
wiley   +1 more source

The prospective roles of exosomes in pituitary tumors. [PDF]

open access: yesFront Endocrinol (Lausanne)
Lisiewicz P   +3 more
europepmc   +1 more source

Pathologic Characteristics of Somatotroph Pituitary Tumors-An Observational Single-Center Study. [PDF]

open access: yesBiomedicines, 2023
Tomasik A   +7 more
europepmc   +1 more source

Lung adenocarcinoma metastasis within a pituitary neuroendocrine tumor: a case report with review of literature

open access: diamond, 2023
Koji Suzuki   +8 more
openalex   +2 more sources

Magnetic resonance imaging features of hypophysitis in patients with cancer treated with immune checkpoint inhibitors

open access: yesJournal of Neuroendocrinology, EarlyView.
This study evaluated pituitary MRI results in cancer patients who experienced immune‐related hypophysitis while receiving immune checkpoint inhibitor treatment. MRI abnormalities were present in 63% of patients at follow‐up and 56% of patients at diagnosis, mostly in patients with multiple hormonal deficiencies.
Anna Angelousi   +10 more
wiley   +1 more source

Pangenomic Classification of Pituitary Neuroendocrine Tumors.

open access: yesCancer Cell, 2019
Mario B. Néou   +22 more
semanticscholar   +1 more source

The gatekeepers of growth: The neural roles and regulation of growth hormone‐releasing hormone neurons

open access: yesJournal of Neuroendocrinology, EarlyView.
Abstract The neuroendocrine control of growth is mediated by the hypothalamic–pituitary–somatic (HPS) axis. This involves the hypothalamic release of growth hormone‐releasing hormone (GHRH), which stimulates the pituitary secretion of growth hormone (GH).
Bradley B. Jamieson
wiley   +1 more source

Home - About - Disclaimer - Privacy